Sync for Science-a collaboration between the National Institutes of Health, Office of the National Coordinator for Health IT, and Harvard Medical School-will allow patients to access their own health data, which they can then share with researchers involved in the initiative.
A year after the government announced the Precision Medicine Initiative (PMI), the Sync for Science (S4S) program—a collaboration between the National Institutes of Health (NIH), Office of the National Coordinator for Health IT (ONC), and Harvard Medical School—has opened up avenues for patient participation, allowing patients access to their own health data that they can then share with researchers involved in the initiative.
For the pilot programs to be launched soon, ONC, NIH, and the Harvard researchers expect to collect personal health data from over a million participants across the nation through a collaboration with electronic health record (EHR) developers (Allscripts, athenahealth, Cerner, drchrono, Epic, and McKesson). This HIPAA-compliant process plans to:
This massive interoperability project is expected to allow a more personalized approach through patient participation, improve researcher access to basic clinical data, free provider staff time, and develop a much stronger knowledge base that will empower providers, research scientists, and ultimately the healthcare system.
Interoperability remains high on the governments list of healthcare priorities. At the recent annual meeting of the Health Information Management Systems Society, HHS Secretary Sylvia M. Burwell said, “Technology isn’t just one leg of our strategy to build a better healthcare system for our nation, it supports the entire effort. We are working to unlock healthcare data and information so that providers are better informed and patients and families can access their healthcare information, making them empowered, active participants in their own care.”
The S4S program does not plan to develop new standards; rather, they will build on existing open community efforts such as FHIR, SMART Health IT, Argonaut, and the CMS EHR Incentive Program. Of the million participants, 700,000 will be enrolled through their health providers, while the remaining 300,000 are expected to enroll independently through S4S.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More